Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascarenhas

Showing results (11-20 of 3,365) with videos related to

Pageof 337
Sort By:
Australian Journal of Primary Health|July 10, 2025
Searching for Utopia: emerging models for primary care in 21st century AustraliaLester Mascarenhas
Nature Biotechnology|November 5, 1997
Sustaining biotechnology education initiativesD Mascarenhas
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
A Concise Update on Risk Factors, Therapy, and Outcome of Leukemic Transformation of Myeloproliferative NeoplasmsJohn Mascarenhas
The Journal of Bone and Joint Surgery. American Volume|August 6, 2021
Pediatric and Adolescent ACL Reconstruction: Is Delaying Surgery Doing More Harm Than Good?: Commentary on an article by David A. Kolin, BA, MSc, et al.: "ACL Reconstruction Delay in Pediatric and Adolescent Patients Is Associated with an Increased Risk of Medial Meniscal Tears"Randy Mascarenhas
Blood|December 2, 2021
Mutations in MPNs to "interfere-on"John Mascarenhas
Leukemia & Lymphoma|January 15, 2015
Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosisJohn Mascarenhas
Journal of Evaluation in Clinical Practice|February 26, 2009
The Manitoba arthroplasty waiting list: impact on health-related quality of life and initiatives to remedy the problemRandy Mascarenhas
Neuro-Chirurgie|October 28, 2011
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematomaL Mascarenhas
Acta Medica Portuguesa|March 5, 2020
[On the Need to Promote the Primary Prevention of Head Injury]Lino Mascarenhas
Hematology. American Society of Hematology. Education Program|December 6, 2015
Looking forward: novel therapeutic approaches in chronic and advanced phases of myelofibrosisJohn Mascarenhas
Pageof 337

Showing results (11-20 of 3,365) with videos related to

Sort By:
Pageof 337
Australian Journal of Primary Health|July 10, 2025
Searching for Utopia: emerging models for primary care in 21st century AustraliaLester Mascarenhas
Nature Biotechnology|November 5, 1997
Sustaining biotechnology education initiativesD Mascarenhas
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
A Concise Update on Risk Factors, Therapy, and Outcome of Leukemic Transformation of Myeloproliferative NeoplasmsJohn Mascarenhas
The Journal of Bone and Joint Surgery. American Volume|August 6, 2021
Pediatric and Adolescent ACL Reconstruction: Is Delaying Surgery Doing More Harm Than Good?: Commentary on an article by David A. Kolin, BA, MSc, et al.: "ACL Reconstruction Delay in Pediatric and Adolescent Patients Is Associated with an Increased Risk of Medial Meniscal Tears"Randy Mascarenhas
Blood|December 2, 2021
Mutations in MPNs to "interfere-on"John Mascarenhas
Leukemia & Lymphoma|January 15, 2015
Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosisJohn Mascarenhas
Journal of Evaluation in Clinical Practice|February 26, 2009
The Manitoba arthroplasty waiting list: impact on health-related quality of life and initiatives to remedy the problemRandy Mascarenhas
Neuro-Chirurgie|October 28, 2011
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematomaL Mascarenhas
Acta Medica Portuguesa|March 5, 2020
[On the Need to Promote the Primary Prevention of Head Injury]Lino Mascarenhas
Hematology. American Society of Hematology. Education Program|December 6, 2015
Looking forward: novel therapeutic approaches in chronic and advanced phases of myelofibrosisJohn Mascarenhas
Pageof 337